Caspase-2 modulates osteoclastogenesis through down-regulating oxidative stress

Danielle A. Callaway, Manuel A. Riquelme, Ramaswamy Sharma, Marisa Lopez-Cruzan, Brian A. Herman, Jean X. Jiang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The loss of caspase-2 (Casp-2) in mice results in an osteopenic phenotype associated with increased numbers of osteoclasts in vivo. In this study, we show that Casp-2 is involved in osteoclastogenesis. Protein levels of Casp-2 decrease during the differentiation of macrophages to osteoclasts. Furthermore, siRNA-mediated Casp-2 knockdown in osteoclast precursors or differentiation of bone marrow macrophage (BMM) precursors from Casp2 -/- mice results in increased osteoclast numbers and tartrate-resistant acid phosphatase (TRAP) activity. Casp2 -/- osteoclasts are larger in size compared to wild-type osteoclasts and exhibited increased numbers of nuclei, perhaps due to increased precursor fusion. The loss of Casp-2 did not alter earlier stages of differentiation, but had a greater consequence on later stages involving NFATc1 auto-amplification and pre-osteoclast fusion. We have previously shown that the loss of Casp-2 results in increased oxidative stress in the bone. Reactive oxygen species (ROS) is known to play a critical role in late osteoclast differentiation and we show that total ROS and specifically, mitochondrial ROS, significantly increased in Casp2 -/- BMM precursors after RANKL administration, with a concomitant reduction in FoxO3a and its target antioxidant enzymes, catalase and superoxide 2 (SOD2). Because mitochondrial ROS has been identified as a putative regulator of the later stages of differentiation, the heightened ROS levels in Casp2 -/- cells likely promote precursor fusion and increased osteoclast numbers. In conclusion, our results indicate a novel role of Casp-2 in the osteoclast as a modulator of total and mitochondrial ROS and osteoclast differentiation.

Original languageEnglish (US)
Pages (from-to)40-48
Number of pages9
JournalBone
Volume76
DOIs
StatePublished - Jul 1 2015

Fingerprint

Caspase 2
Osteoclasts
Osteogenesis
Oxidative Stress
Reactive Oxygen Species
Macrophages
Bone Marrow
Superoxides
Catalase
Small Interfering RNA

Keywords

  • Caspase-2
  • Osteoclastogenesis
  • Oxidative stress

Cite this

Callaway, D. A., Riquelme, M. A., Sharma, R., Lopez-Cruzan, M., Herman, B. A., & Jiang, J. X. (2015). Caspase-2 modulates osteoclastogenesis through down-regulating oxidative stress. Bone, 76, 40-48. https://doi.org/10.1016/j.bone.2015.03.006

Caspase-2 modulates osteoclastogenesis through down-regulating oxidative stress. / Callaway, Danielle A.; Riquelme, Manuel A.; Sharma, Ramaswamy; Lopez-Cruzan, Marisa; Herman, Brian A.; Jiang, Jean X.

In: Bone, Vol. 76, 01.07.2015, p. 40-48.

Research output: Contribution to journalArticle

Callaway, DA, Riquelme, MA, Sharma, R, Lopez-Cruzan, M, Herman, BA & Jiang, JX 2015, 'Caspase-2 modulates osteoclastogenesis through down-regulating oxidative stress' Bone, vol. 76, pp. 40-48. https://doi.org/10.1016/j.bone.2015.03.006
Callaway, Danielle A. ; Riquelme, Manuel A. ; Sharma, Ramaswamy ; Lopez-Cruzan, Marisa ; Herman, Brian A. ; Jiang, Jean X. / Caspase-2 modulates osteoclastogenesis through down-regulating oxidative stress. In: Bone. 2015 ; Vol. 76. pp. 40-48.
@article{f4e2eec3b4d342b5990b6a57cf89f7b2,
title = "Caspase-2 modulates osteoclastogenesis through down-regulating oxidative stress",
abstract = "The loss of caspase-2 (Casp-2) in mice results in an osteopenic phenotype associated with increased numbers of osteoclasts in vivo. In this study, we show that Casp-2 is involved in osteoclastogenesis. Protein levels of Casp-2 decrease during the differentiation of macrophages to osteoclasts. Furthermore, siRNA-mediated Casp-2 knockdown in osteoclast precursors or differentiation of bone marrow macrophage (BMM) precursors from Casp2 -/- mice results in increased osteoclast numbers and tartrate-resistant acid phosphatase (TRAP) activity. Casp2 -/- osteoclasts are larger in size compared to wild-type osteoclasts and exhibited increased numbers of nuclei, perhaps due to increased precursor fusion. The loss of Casp-2 did not alter earlier stages of differentiation, but had a greater consequence on later stages involving NFATc1 auto-amplification and pre-osteoclast fusion. We have previously shown that the loss of Casp-2 results in increased oxidative stress in the bone. Reactive oxygen species (ROS) is known to play a critical role in late osteoclast differentiation and we show that total ROS and specifically, mitochondrial ROS, significantly increased in Casp2 -/- BMM precursors after RANKL administration, with a concomitant reduction in FoxO3a and its target antioxidant enzymes, catalase and superoxide 2 (SOD2). Because mitochondrial ROS has been identified as a putative regulator of the later stages of differentiation, the heightened ROS levels in Casp2 -/- cells likely promote precursor fusion and increased osteoclast numbers. In conclusion, our results indicate a novel role of Casp-2 in the osteoclast as a modulator of total and mitochondrial ROS and osteoclast differentiation.",
keywords = "Caspase-2, Osteoclastogenesis, Oxidative stress",
author = "Callaway, {Danielle A.} and Riquelme, {Manuel A.} and Ramaswamy Sharma and Marisa Lopez-Cruzan and Herman, {Brian A.} and Jiang, {Jean X.}",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.bone.2015.03.006",
language = "English (US)",
volume = "76",
pages = "40--48",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Caspase-2 modulates osteoclastogenesis through down-regulating oxidative stress

AU - Callaway, Danielle A.

AU - Riquelme, Manuel A.

AU - Sharma, Ramaswamy

AU - Lopez-Cruzan, Marisa

AU - Herman, Brian A.

AU - Jiang, Jean X.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - The loss of caspase-2 (Casp-2) in mice results in an osteopenic phenotype associated with increased numbers of osteoclasts in vivo. In this study, we show that Casp-2 is involved in osteoclastogenesis. Protein levels of Casp-2 decrease during the differentiation of macrophages to osteoclasts. Furthermore, siRNA-mediated Casp-2 knockdown in osteoclast precursors or differentiation of bone marrow macrophage (BMM) precursors from Casp2 -/- mice results in increased osteoclast numbers and tartrate-resistant acid phosphatase (TRAP) activity. Casp2 -/- osteoclasts are larger in size compared to wild-type osteoclasts and exhibited increased numbers of nuclei, perhaps due to increased precursor fusion. The loss of Casp-2 did not alter earlier stages of differentiation, but had a greater consequence on later stages involving NFATc1 auto-amplification and pre-osteoclast fusion. We have previously shown that the loss of Casp-2 results in increased oxidative stress in the bone. Reactive oxygen species (ROS) is known to play a critical role in late osteoclast differentiation and we show that total ROS and specifically, mitochondrial ROS, significantly increased in Casp2 -/- BMM precursors after RANKL administration, with a concomitant reduction in FoxO3a and its target antioxidant enzymes, catalase and superoxide 2 (SOD2). Because mitochondrial ROS has been identified as a putative regulator of the later stages of differentiation, the heightened ROS levels in Casp2 -/- cells likely promote precursor fusion and increased osteoclast numbers. In conclusion, our results indicate a novel role of Casp-2 in the osteoclast as a modulator of total and mitochondrial ROS and osteoclast differentiation.

AB - The loss of caspase-2 (Casp-2) in mice results in an osteopenic phenotype associated with increased numbers of osteoclasts in vivo. In this study, we show that Casp-2 is involved in osteoclastogenesis. Protein levels of Casp-2 decrease during the differentiation of macrophages to osteoclasts. Furthermore, siRNA-mediated Casp-2 knockdown in osteoclast precursors or differentiation of bone marrow macrophage (BMM) precursors from Casp2 -/- mice results in increased osteoclast numbers and tartrate-resistant acid phosphatase (TRAP) activity. Casp2 -/- osteoclasts are larger in size compared to wild-type osteoclasts and exhibited increased numbers of nuclei, perhaps due to increased precursor fusion. The loss of Casp-2 did not alter earlier stages of differentiation, but had a greater consequence on later stages involving NFATc1 auto-amplification and pre-osteoclast fusion. We have previously shown that the loss of Casp-2 results in increased oxidative stress in the bone. Reactive oxygen species (ROS) is known to play a critical role in late osteoclast differentiation and we show that total ROS and specifically, mitochondrial ROS, significantly increased in Casp2 -/- BMM precursors after RANKL administration, with a concomitant reduction in FoxO3a and its target antioxidant enzymes, catalase and superoxide 2 (SOD2). Because mitochondrial ROS has been identified as a putative regulator of the later stages of differentiation, the heightened ROS levels in Casp2 -/- cells likely promote precursor fusion and increased osteoclast numbers. In conclusion, our results indicate a novel role of Casp-2 in the osteoclast as a modulator of total and mitochondrial ROS and osteoclast differentiation.

KW - Caspase-2

KW - Osteoclastogenesis

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84925764971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925764971&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2015.03.006

DO - 10.1016/j.bone.2015.03.006

M3 - Article

VL - 76

SP - 40

EP - 48

JO - Bone

JF - Bone

SN - 8756-3282

ER -